Carnauba Wax.

Carnauba wax and beeswax are combined as the polishing layer over a finished tablet or softgel, where the harder carnauba gives gloss and the softer beeswax gives the film flexibility. Neither is absorbed in any meaningful amount; the pairing is a surface finish that reduces tackiness and moisture pickup.

Carnauba wax is buffed over an HPMC film coat as the final polish, because the cellulose film carries the barrier and the wax carries the gloss and slip. The wax layer also lowers friction so coated tablets do not bind against each other in the bottle.

Magnesium stearate lubricates the powder blend inside the die while carnauba wax finishes the outside of the compressed tablet. Both are hydrophobic, so a formula heavy in each can slow water ingress and lengthen disintegration time. Dissolution testing is what settles whether that matters for a given tablet.

Colloidal silicon dioxide keeps a powder blend flowing into the die, and carnauba wax is applied after compression as the polish. Powdered carnauba is itself sometimes co-blended with silica to stay free flowing in the coating pan. The pairing is purely about handling.

A hypromellose film coat carries the colour and the barrier, then carnauba wax is polished onto that film for gloss and to reduce friction in the bottle. The wax layer is thin enough that it does not by itself define the release profile. This is standard finishing practice.

Microcrystalline cellulose provides the compressible bulk of most tablets and wicks water in to help the tablet break apart. A hydrophobic wax finish works against that wicking at the surface. The two are balanced against each other during disintegration testing rather than being synergistic in any biological sense.

Stearic acid works as a lubricant and a hydrophobic matrix former, sitting in the same functional family as carnauba wax. Both raise the melting profile of a formulation and both resist moisture. Neither is absorbed in any meaningful amount at excipient levels.

Carnauba wax has been tested as a microencapsulation shell for arginine, with the wax shielding the amino acid from degradation before its intended release point. The published work is in animal feeding, not in people. The relationship is delivery engineering, not a nutritional interaction.

Wax-protected lysine has been fed to ruminants specifically so the amino acid survives the rumen and reaches the small intestine intact. That is a non-human digestive problem with no direct human parallel. It is cited here as evidence that the wax functions as a protective matrix, nothing more.

Carnauba wax forms a continuous hydrophobic film with very low oxygen and moisture permeability, which is why lipid waxes are used to encapsulate carotenoids and other oxidation-prone actives. The wax slows contact between the active and atmospheric oxygen during shelf life. It affects stability of the ingredient, not its absorption once released.